A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

10.1007/s11523-023-00997-z

Saved in:

Bibliographic Details
Main Authors:	Razak, Albiruni R Abdul, Wang, Hung-Ming, Chang, Jang-Yang, Ahn, Myung-Ju, Munster, Pamela, Blumenschein Jr, George, Solomon, Benjamin, Lim, Darren Wan-Teck, Hong, Ruey-Long, Pfister, David, Saba, Nabil F, Lee, Se-Hoon, van Herpen, Carla, Quadt, Cornelia, Bootle, Douglas, Blumenstein, Lars, Demanse, David, Delord, Jean-Pierre
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Language:	English
Published:	SPRINGER 2024
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR IRRADIATION PX-866 TRIAL MODEL
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/248889
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Be the first to leave a comment!